Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
PRTC
vs
F
FTSE All Share Index
PRTC
Over the past 12 months, PRTC has outperformed FTSE All Share Index, delivering a return of +0% compared to FTSE All Share Index's 0% growth.
Stocks Performance
PRTC vs FTSE All Share Index
Performance Gap
PRTC vs FTSE All Share Index
Create a free account · No card needed
Performance By Year
PRTC vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PureTech Health PLC
Glance View
PureTech Health is a biotechnology company that builds and develops new medicines for hard-to-treat diseases. It starts with scientific ideas around biology and turns them into drug programs, often by creating or backing separate portfolio companies to carry the work forward. Its value comes from discovering promising therapies, advancing them through research and clinical testing, and partnering or spinning them out when they reach the right stage. The company does not sell consumer products. Its business is tied to drug development, so its customers and counterparties are mainly pharmaceutical partners, investors in its portfolio companies, and eventually patients and healthcare providers if a therapy reaches market. PureTech can make money through licensing deals, collaboration payments, equity stakes in its spinouts, and future royalties or milestones if its drug candidates succeed. What makes PureTech different is its role as an innovation builder rather than a traditional drugmaker. It focuses on early-stage science and uses a portfolio approach to spread risk across several programs and companies. That gives it a position between academic discovery and large pharmaceutical commercialization, with value tied to whether its research platform can produce drugs that other companies want to develop and sell.
Create a free account · No card needed
